Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Ann Saudi Med ; 41(6): 313-317, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34873935

RESUMEN

BACKGROUND: Intravascular intrauterine transfusion (IUT) is considered a safe procedure, but complications still occur, including fatalities. OBJECTIVE: Review the outcomes of Rh alloimmunization, including indications and possible complications. DESIGN: Retrospective cohort (medical record review). SETTING: Tertiary care center. PATIENTS AND METHODS: We retrieved the records for all mothers who had an IUT for Rh alloimmunization between January 2009 and August 2019. We collected data on complications, post-transfusion hemoglobin and antibody combinations. MAIN OUTCOME MEASURE: Complications of IUT. SAMPLE SIZE: 119 mothers with 154 fetuses (154 different pregnancies). RESULTS: The 154 fetuses had 560 intrauterine transfusions. The median pre-IUT hemoglobin was a median of 8.0 g/dL while the median post-IUT hemoglobin 16 g/dL. Immediate procedure-related complications included fetal bradycardia in 2.7%, significant bleeding from the cord puncture site (for more than 2 minutes in 0.9%), and contractions in 0.9%. Eight (5.2%) were delivered by cesarean delivery due to IUT-specific complications such as post-procedure fetal bradycardia. Intrauterine fetal death complicated 8.4% of the pregnancies (13 fetuses). Phototherapy was required in 76 (49.4%), postnatal blood transfusions in 17 (11%), and exchange transfusion in 11 (7.1%). Neonatal death occurred 8 (5.2%). Data were insufficient to assess associations of complications with antibody combinations. CONCLUSIONS: Intrauterine transfusion is an effective treatment with high survival rates (around 90% for cases of Rh alloimmunization). LIMITATIONS: Case series. CONFLICT OF INTEREST: None.


Asunto(s)
Transfusión de Sangre Intrauterina , Muerte Fetal , Transfusión Sanguínea , Transfusión de Sangre Intrauterina/efectos adversos , Estudios de Cohortes , Femenino , Humanos , Recién Nacido , Embarazo , Estudios Retrospectivos
2.
J Obstet Gynaecol Res ; 40(1): 293-6, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24102864

RESUMEN

Maternal floor infarction is a relatively rare condition characterized clinically by severe early onset fetal growth restriction with features of uteroplacental insufficiency. It has a very high recurrence rate and carries a significant risk or fetal demise. Pathological characteristics include massive and diffuse fibrin deposition along the decidua basalis and the perivillous space of the basal plate. We present a case of recurrent maternal floor infarction and propose diagnostic clues as well as potential therapeutic options.


Asunto(s)
Retardo del Crecimiento Fetal/etiología , Infarto/fisiopatología , Placenta/irrigación sanguínea , Circulación Placentaria , Insuficiencia Placentaria/fisiopatología , Adulto , Femenino , Muerte Fetal/etiología , Retardo del Crecimiento Fetal/prevención & control , Fibrina/metabolismo , Humanos , Infarto/patología , Infarto/prevención & control , Infarto/terapia , Placenta/metabolismo , Placenta/patología , Insuficiencia Placentaria/patología , Insuficiencia Placentaria/prevención & control , Insuficiencia Placentaria/terapia , Embarazo , Prevención Secundaria , Índice de Severidad de la Enfermedad , Regulación hacia Arriba , Enfermedades Uterinas/patología , Enfermedades Uterinas/fisiopatología , Enfermedades Uterinas/prevención & control , Enfermedades Uterinas/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...